{"id":22433,"date":"2025-05-22T18:02:08","date_gmt":"2025-05-22T18:02:08","guid":{"rendered":"https:\/\/zennihost.com\/test\/2025\/05\/22\/aspak-bindes-fda-i-bllokon-pfizer-it-ilacin-per-kancerin-e-prostates\/"},"modified":"2025-05-22T18:02:08","modified_gmt":"2025-05-22T18:02:08","slug":"aspak-bindes-fda-i-bllokon-pfizer-it-ilacin-per-kancerin-e-prostates","status":"publish","type":"post","link":"https:\/\/zennihost.com\/test\/2025\/05\/22\/aspak-bindes-fda-i-bllokon-pfizer-it-ilacin-per-kancerin-e-prostates\/","title":{"rendered":"\u201cAspak bind\u00ebs\u201d \u2013 FDA i bllokon Pfizer-it ila\u00e7in p\u00ebr kancerin e prostat\u00ebs"},"content":{"rendered":"<p>Pfizer nuk arriti t\u00eb bind\u00eb k\u00ebshilltar\u00ebt e Administrat\u00ebs s\u00eb Ushqimit dhe Barnave t\u00eb SHBA-s\u00eb p\u00ebr t\u00eb mb\u00ebshtetur nj\u00eb zgjerim t\u00eb madh n\u00eb p\u00ebrdorimin e ila\u00e7it t\u00eb saj p\u00ebr kancerin e prostat\u00ebs, nj\u00eb penges\u00eb q\u00eb mund t\u00eb shkat\u00ebrroj\u00eb ambiciet e kompanis\u00eb p\u00ebr trajtimin.<\/p>\n<p>Nj\u00eb grup ekspert\u00ebsh t\u00eb pavarur votuan nj\u00ebz\u00ebri se Pfizer nuk paraqiti t\u00eb dh\u00ebna bind\u00ebse p\u00ebr t\u00eb zgjeruar miratimin e Talzenna, nj\u00eb pilul\u00eb e p\u00ebrdorur tani p\u00ebr tani p\u00ebr nj\u00eb grup pacient\u00ebsh me kancer t\u00eb prostat\u00ebs q\u00eb ka mutacione gjenetike specifike. FDA-s\u00eb nuk i k\u00ebrkohet t\u00eb ndjek\u00eb votat e k\u00ebshilltar\u00ebve t\u00eb saj, por zakonisht e b\u00ebn k\u00ebt\u00eb.<\/p>\n<p>Pfizer po k\u00ebrkon t\u00eb trefishoj\u00eb numrin e njer\u00ebzve t\u00eb kualifikuar p\u00ebr Talzenna n\u00eb SHBA, duke treguar nj\u00eb prov\u00eb klinike ku duket se mjekimi zgjati mbijetes\u00ebn te pacient\u00ebt me s\u00ebmundje rezistente ndaj kastrimit, pavar\u00ebsisht nga statusi i tyre gjenetik, shkruan Bloomberg.<\/p>\n<p>FDA-ja dhe k\u00ebshilltar\u00ebt e saj kund\u00ebrshtuan studimin mb\u00ebshtet\u00ebs t\u00eb Pfizer, me disa ekspert\u00eb q\u00eb argumentuan se kompania d\u00ebshtoi t\u00eb provonte q\u00eb Talzenna i sillte ndonj\u00eb p\u00ebrfitim pacient\u00ebve pa mutacione gjenetike dhe ngrit\u00ebn shqet\u00ebsime se rezultati n\u00eb dukje pozitiv ishte p\u00ebr shkak t\u00eb mund\u00ebsive t\u00eb rast\u00ebsishme.<\/p>\n<p>\u201c\u00cbsht\u00eb e barabart\u00eb me dik\u00eb q\u00eb gjuan nj\u00eb shigjet\u00eb n\u00eb mur dhe m\u00eb pas pikturon nj\u00eb objektiv rreth tij,\u201d tha Richard Pazdur, i cili drejton divizionin e onkologjis\u00eb t\u00eb FDA-s\u00eb dhe kryeson miratimin e ila\u00e7eve t\u00eb reja kund\u00ebr kancerit.<\/p>\n<p>Talzenna \u00ebsht\u00eb n\u00eb mesin e nj\u00eb numri t\u00eb vog\u00ebl ila\u00e7esh kund\u00ebr kancerit q\u00eb Pfizer pret t\u00eb kthehen n\u00eb trajtime shum\u00eb miliarda dollar\u00ebshe n\u00eb vitet n\u00eb vijim. Shitjet e produkteve t\u00eb kompanis\u00eb Covid kan\u00eb r\u00ebn\u00eb n\u00eb m\u00ebnyr\u00eb dramatike q\u00eb nga kulmi i pandemis\u00eb dhe Pfizer do humbas\u00eb rreth 15 miliard\u00eb dollar\u00eb t\u00eb ardhura vjetore deri n\u00eb fund t\u00eb dekad\u00ebs pasi ila\u00e7et e vjetra humbasin mbrojtjen e patentave.<\/p>\n<p>The post <a href=\"https:\/\/lexo.al\/2025\/05\/aspak-bindes-fda-i-bllokon-pfizer-it-ilacin-per-kancerin-e-prostates\/\">\u201cAspak bind\u00ebs\u201d \u2013 FDA i bllokon Pfizer-it ila\u00e7in p\u00ebr kancerin e prostat\u00ebs<\/a> appeared first on <a href=\"https:\/\/lexo.al\/\">www.lexo.al<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Pfizer nuk arriti t\u00eb bind\u00eb k\u00ebshilltar\u00ebt e Administrat\u00ebs s\u00eb Ushqimit dhe Barnave t\u00eb SHBA-s\u00eb p\u00ebr t\u00eb mb\u00ebshtetur nj\u00eb zgjerim t\u00eb madh n\u00eb p\u00ebrdorimin e ila\u00e7it t\u00eb saj p\u00ebr kancerin e prostat\u00ebs, nj\u00eb penges\u00eb q\u00eb mund t\u00eb shkat\u00ebrroj\u00eb ambiciet e kompanis\u00eb p\u00ebr trajtimin. Nj\u00eb grup ekspert\u00ebsh t\u00eb pavarur votuan nj\u00ebz\u00ebri se Pfizer nuk paraqiti t\u00eb dh\u00ebna [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-22433","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/posts\/22433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/comments?post=22433"}],"version-history":[{"count":0,"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/posts\/22433\/revisions"}],"wp:attachment":[{"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/media?parent=22433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/categories?post=22433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zennihost.com\/test\/wp-json\/wp\/v2\/tags?post=22433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}